BIOMAT Database Logo BIOMAT Database Logo

Thrombolytic effect of urokinase on artificial thrombi in vitro. 1969

T Suyama, and S Odashima, and Y Iga, and Y Shibuya

UI MeSH Term Description Entries
D005343 Fibrinolytic Agents Fibrinolysin or agents that convert plasminogen to FIBRINOLYSIN. Antithrombic Drug,Antithrombotic Agent,Antithrombotic Agents,Fibrinolytic Agent,Fibrinolytic Drug,Thrombolytic Agent,Thrombolytic Agents,Thrombolytic Drug,Antithrombic Drugs,Fibrinolytic Drugs,Thrombolytic Drugs,Agent, Antithrombotic,Agent, Fibrinolytic,Agent, Thrombolytic,Agents, Antithrombotic,Drug, Antithrombic,Drug, Fibrinolytic,Drug, Thrombolytic,Drugs, Antithrombic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013300 Streptokinase Streptococcal fibrinolysin . An enzyme produced by hemolytic streptococci. It hydrolyzes amide linkages and serves as an activator of plasminogen. It is used in thrombolytic therapy and is used also in mixtures with streptodornase (STREPTODORNASE AND STREPTOKINASE). EC 3.4.-. Avelizin,Awelysin,Celiase,Distreptase,Kabikinase,Kabivitrum,Streptase,Streptodecase
D013927 Thrombosis Formation and development of a thrombus or blood clot in BLOOD VESSELS. Atherothrombosis,Thrombus,Blood Clot,Blood Clots,Thromboses
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Observations on the lysis of artificial thrombi by urokinase.
March 1968, Thrombosis et diathesis haemorrhagica,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Factors influencing the lysis of artificial thrombi by urokinase.
January 1967, Scandinavian journal of haematology,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
August 2017, Circulation,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
In vitro culture of artificial thrombi.
January 1969, Angiology,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Thrombolysis in vitro. II. Thrombolytic effect of streptokinase and urokinase in health and disease.
January 1965, Scandinavian journal of clinical and laboratory investigation,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
[Thrombolytic therapy. Effect of urokinase on experimental thrombosis (author's transl)].
June 1977, [Rinsho ketsueki] The Japanese journal of clinical hematology,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
[The thrombolytic action of urokinase enhanced by prostaglandin E1 in vitro].
December 1992, Zhonghua xin xue guan bing za zhi,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Assessment of the thrombolytic effect of low urokinase concentrations.
June 1976, Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
Ancrod enhances the thrombolytic effect of streptokinase and urokinase.
August 1987, Thrombosis research,
T Suyama, and S Odashima, and Y Iga, and Y Shibuya
[Study on defibrinogenasing enhancing the thrombolytic effect of urokinase on acute myocardial infarction].
August 2003, Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue,
Copied contents to your clipboard!